Dogwood Therapeutics, Inc. financial data

Symbol
DWTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
44 Milton Avenue, Alpharetta, GA
State of incorporation
DE
Fiscal year end
December 31
Former names
Virios Therapeutics, Inc. (to 10/15/2024), Virios Therapeutics, LLC (to 12/16/2020)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 460 % -58.3%
Debt-to-equity -958 % -9723%
Return On Equity 1.46K %
Return On Assets -47.8 % +52.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.91M shares -90.1%
Common Stock, Shares, Outstanding 1.33M shares +72.9%
Entity Public Float 5.76M USD -76.4%
Common Stock, Value, Issued 133 USD +72.7%
Weighted Average Number of Shares Outstanding, Basic 1.03M shares +36.8%
Weighted Average Number of Shares Outstanding, Diluted 1.03M shares +36.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.53M USD +104%
General and Administrative Expense 8.7M USD +134%
Operating Income (Loss) -12.2M USD -124%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.4M USD -133%
Net Income (Loss) Attributable to Parent -12.3M USD -133%
Earnings Per Share, Basic -12.5 USD/shares -77.6%
Earnings Per Share, Diluted -12.5 USD/shares -77.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.8M USD +348%
Assets, Current 16.5M USD +297%
Property, Plant and Equipment, Net 16.8K USD
Operating Lease, Right-of-Use Asset 206K USD
Intangible Assets, Net (Excluding Goodwill) 65.7M USD
Goodwill 11.8M USD
Assets 94.3M USD +2164%
Accounts Payable, Current 1.23M USD +1001%
Employee-related Liabilities, Current 737K USD
Accrued Liabilities, Current 1.89M USD +668%
Liabilities, Current 3.18M USD +786%
Deferred Income Tax Liabilities, Net 11.3M USD
Operating Lease, Liability, Noncurrent 155K USD
Other Liabilities, Noncurrent 15.4M USD
Liabilities 30M USD +8275%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.86M USD
Retained Earnings (Accumulated Deficit) -73.8M USD -20.1%
Stockholders' Equity Attributable to Parent -10.1M USD -366%
Liabilities and Equity 94.3M USD +2164%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -937K USD +44.8%
Common Stock, Shares Authorized 43M shares 0%
Common Stock, Shares, Issued 1.34M shares +72.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.8M USD +348%
Deferred Tax Assets, Valuation Allowance 31.4M USD +216%
Deferred Tax Assets, Gross 38.3M USD +277%
Operating Lease, Liability 205K USD
Lessee, Operating Lease, Liability, to be Paid 234K USD
Property, Plant and Equipment, Gross 18.4K USD
Operating Lease, Liability, Current 49.7K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 63.9K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 63.5K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 65K USD
Deferred Tax Assets, Operating Loss Carryforwards 26.1M USD +266%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares -0.11%
Lessee, Operating Lease, Liability, to be Paid, Year Four 41.8K USD
Operating Lease, Payments 31.9K USD
Additional Paid in Capital 67.9M USD +3.48%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.9M USD +3102%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%